Haier Gene Technology Nucleic Acid Testing Program To Help New Crown Outbreak Prevention and Control

at present, the domestic new corona epidemic has been effectively contained, but with the spread of the epidemic in the world, the domestic still can not be alert to the general effect, but also need to strictly prevent foreign imported cases and suspected confirmed and confirmed cases in the process of centralized isolation treatment of other respiratory virus infection, co-infection, and the resulting cross-infectionNingbo Haier Gene Technology Co., Ltdresearch and development and production of "13 kinds of respiratory pathogens multi-test kit (National Firearms 20183400518)," with its newly launched SARS-CoV-2 new coronavirus nucleic acid testing kit, can help identify diagnosis, assist the new coronal diagnosis; At present, two products have been EU CE certification1Product introduction
The product uses multiple PCR and capillary electrophoresis technology, can be in a PCR amplification reaction tube at the same time for respiratory samples of 13 respiratory pathogens nucleic acid testing, to avoid leakage, for doctors to clearly judge the type of pathogens infected by patients, choose the right treatment plan to help, and effectively avoid the abuse of antibiotics, for patients to obtain the right treatment program to win valuable time; the types ofdetected pathogens include:eight common respiratory viruses recommended in the Guidelines for Technical Review of Multi-Nucleic Acid Testing Reagents for Respiratory Viruss issued by the State Drug Administration, and the(2) Pneumonia Treatment Programme for New Coronary Virus Infections (Trial Seventh Edition) to identify viruses and pneumonic pathogens highlighted by diagnosis;It is a multi-PCR nucleic acid testing reagent with NMPA registration requirements to meet the diagnostic and treatment of pneumonia for the new coronavirus infection (trial 7th edition), which can provide comprehensive, high-quality pathogen test results for the differential diagnosis of new coronavirus infection, which is conducive to the prevention and control of the epidemic and clinical diagnosis and treatment2Multi-PCR nucleic acid testing, to assist the epidemic prevention and control"new coronavirus infection pneumonia diagnosis and treatment program (trial 7th edition) (National Health Administration Medical Letter ( 2020) 184) shows that: differential diagnosis, especially through multiple PCR nucleic acid testing, in the new coronary pneumonia diagnosis and treatment has a very important clinical significance:(i) the light performance of new coronavirus infection with other virus-induced upper respiratory infections(2) The new coronavirus pneumonia is mainly associated with influenza virus, adenovirus, respiratory syncytial virus and other known viral pneumonia and pneumonia mycoplasma infection identification, especially for suspected cases to take as far as possible including rapid antigen detection and multi-PCR nucleic acid testing methods to detect common respiratory pathogens(3) also to identify non-infectious diseases, such as vasculitis, dermatitis and metastasisClinical management of acute acute coVID-19 disease is suspected(Interim guidance 13 March 2020 - World Health Organization)-Remark 3:
Dual s with other other er viraly and infection has had have had had found in SARS, s and COVID-19 patients (8)As a result, a test for a non-COVID-19 not dos rule out COVID-19At this stage, detailed microbiologic studies are have to do all suspected casesBoth URT and LRT scan be tested for other such as viruses, such as as as influenza a and B (the thain zoonotic influenza A), the parainfluenza viruses, rhinoviruses, adenoviruses, enteroviruses (e.gEVD68), human LRT s can also also be be for the neuse-for-bfils, leing Legionella pneumofilaIn malaria-carly-carly-fever with fever be test for the presence of malaria or other co-infections with the wrth diagnostic s (RDTs) or thick and thin blood films and treated as sIn-house settings arbovirus infection (dengue/chikungunya) had a be be considered in the differential diagnosis of unanoed febrile illness, drely thrombocytopenia is presentCo-infection with COVID-19 virus may also also also occur and a positive diagnostic test for dengue (e.gdengue RDTs) dos not the testing for COVID-19 (24).China and WHO official diagnosis and treatment programs have pointed out that not only to detect new coronavirus, but also to the common respiratory virus caused attention, do a good job of identification diagnosis of lung infection, alert to co-infection, under the clear pathogen diagnosis of infection for early diagnosis, disease assessment and targeted treatment, thereby improving prognosis and reducing unnecessary anti-infection treatment3Multi-party data support more reliable Support Information 1: Article Reported: On March 5, an article entitled "8274 cases of new coronavirus nucleic acid testing and co-infection results analysis of 8274 patients in Wuhan region" was published in the Chinese Journal of Testing Medicine The study found that of the 316 new coronavirus nucleic acid-positive patients, 5.77 percent had other respiratory pathogens combined with those infected with common coronaviruses, influenza A virus espresso viruses and rhinoviruses authors suggest that clinical diagnostic methods need to be improved and that attention should be paid to screening respiratory pathogens in addition to new coronaviruses The likelihood of other infections needs to be assessed for clinical classification, isolation, and treatment during the treatment of new crown patients or suspected patients In view of the huge potential for cross-infection, the correspondent Li Yan believes that clinically the need for a broad-spectrum, rapid and accurate respiratory pathogen detection platform to identify pathogens to help determine the disease, while avoiding blind drug use, the need for a rapid screening of as many pathogens as possible at the same time support information II: article reported: February 13, Wuhan Concord Hospital Professor Zhang Jinnon and others published in the Lancet-Respiratory Medicine online "2019 new coronavirus disease (COVID-19) fever outpatient treatment and diversion strategy." The need for differential diagnosis of other viral pneumonia, including influenza viruses and respiratory syncytial viruses, is emphasized Fever patients (temperature of 37.3 degrees Celsius) should first be tested for both chest CT and respiratory viruses support information 3:
article reported: "China Journal of Preventive Medicine" published online in Guangzhou Public Health Expert's paper ," in the fight against the outbreak of new coronavirus pneumonia while alerting to seasonal influenza superposition effects" caused widespread concern The paper argues that the trend of the new coronary pneumonia epidemic is likely to overlap with this year's influenza epidemic season How to more accurately distinguish between infections of different pathogenic microorganisms is particularly important Support Information IV: the State Drug Administration Medical Device Technical Review Center issued the "Respiratory Virus Multi-nucleic acid detection reagent registration technical review guidelines (No 80 of 2019)) recommended testing of the object may include but not limited to: influenza A virus, influenza B, respiratory syncytial virus, para-flu virus, human lung virus, adenovirus, respiratory infection enterovirus (enterovirus/rhinovirus), coronavirus and so on 4 New Coronary Virus Nucleic Acid Testing Kit Nucleic Acid Testing for New Coronaviruses, SARS-CoV-2 Virus Detection Kit Kit (RT-qPCR Method), developed and produced by Ningbo Haier Gene Technology Co., Ltd., using one-step reverse transcription polymerase chain reaction (One Step Step Step RT-PCR) combined with Taqman probe technology, specific primers and probes are designed for the highly conservative region of the gene sequences of the ORF1ab gene, n gene and S gene, respectively, for qualitative testing of the new coronavirus (SARS-CoV-2) RNA With three gene testing, UDG anti-pollution system, endogenous endogenous standard three characteristics, the product has been THE European Union CE certification, and officially by WHO EUL and FDA EUA acceptance references: Wang Ming, etc . Analysis of the results of new coronavirus nucleic acid testing and co-infection in 8274 cases of test subjects in Wuhan 2020 doi: 10.3760/cma.j.cn114452-2020222-00106
Zhang JN, et al and triage strategies for 2019 novel coronavirus disease in fever clinics The Lancettty Medicine 2020 doi.org/10.1016/S2213-2600 (20) 30071-0
.3.Li Steel, Wang Ming Beware of the superposition effects of seasonal influenza while fighting the outbreak of new coronavirus pneumonia doi:10.3760/cma.j.issn.0253-9624.2020.04.001
About Ningbo Haier Gene Technology Co., Ltd.: Ningbo Haier Gene Technology Co., Ltd (HGT), founded in August 2011, main nucleic acid (gene) analysis, molecular diagnostic products research and development, production, sales and application services Adhering to the concept of "making society safer and making life healthier", we are committed to independent research and development and production of nucleic acid molecular detection products with international leading level, providing excellent molecular detection solutions for individual identification, kinship identification, infectious pathogen detection and personalized drug guidance welcome enquiries, hotline: 0574-27978799
Email: contact@healthgenetech.com